Endpoints News
Oral peptides biotech Pinnacle Medicines gets $89M from US, China investors
The pill version of Novo Nordisk’s blockbuster Wegovy showed what was possible when drug chemists turned peptides into oral molecules. Now investors have found their next related bet.
Pinnacle Medicines, a two-year-old startup based in …